Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

555 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Clinical practice. Nondiabetic kidney disease.
Levey AS. Levey AS. N Engl J Med. 2002 Nov 7;347(19):1505-11. doi: 10.1056/NEJMcp013462. N Engl J Med. 2002. PMID: 12421894 Review. No abstract available.
Chronic kidney disease is common: what do we do next?
Coresh J, Stevens LA, Levey AS. Coresh J, et al. Among authors: levey as. Nephrol Dial Transplant. 2008 Apr;23(4):1122-5. doi: 10.1093/ndt/gfn117. Nephrol Dial Transplant. 2008. PMID: 18359871 Review. No abstract available.
Erythropoietic response and outcomes in kidney disease and type 2 diabetes.
Solomon SD, Uno H, Lewis EF, Eckardt KU, Lin J, Burdmann EA, de Zeeuw D, Ivanovich P, Levey AS, Parfrey P, Remuzzi G, Singh AK, Toto R, Huang F, Rossert J, McMurray JJ, Pfeffer MA; Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT) Investigators. Solomon SD, et al. Among authors: levey as. N Engl J Med. 2010 Sep 16;363(12):1146-55. doi: 10.1056/NEJMoa1005109. N Engl J Med. 2010. PMID: 20843249 Clinical Trial.
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.
Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, Feyzi JM, Ivanovich P, Kewalramani R, Levey AS, Lewis EF, McGill JB, McMurray JJ, Parfrey P, Parving HH, Remuzzi G, Singh AK, Solomon SD, Toto R; TREAT Investigators. Pfeffer MA, et al. Among authors: levey as. N Engl J Med. 2009 Nov 19;361(21):2019-32. doi: 10.1056/NEJMoa0907845. Epub 2009 Oct 30. N Engl J Med. 2009. PMID: 19880844 Clinical Trial.
Cystatin C versus creatinine in determining risk based on kidney function.
Shlipak MG, Matsushita K, Ärnlöv J, Inker LA, Katz R, Polkinghorne KR, Rothenbacher D, Sarnak MJ, Astor BC, Coresh J, Levey AS, Gansevoort RT; CKD Prognosis Consortium. Shlipak MG, et al. Among authors: levey as. N Engl J Med. 2013 Sep 5;369(10):932-43. doi: 10.1056/NEJMoa1214234. N Engl J Med. 2013. PMID: 24004120 Free PMC article.
Bardoxolone methyl, chronic kidney disease, and type 2 diabetes.
Upadhyay A, Sarnak MJ, Levey AS. Upadhyay A, et al. Among authors: levey as. N Engl J Med. 2011 Nov 3;365(18):1746; author reply 1746-7. doi: 10.1056/NEJMc1110239. N Engl J Med. 2011. PMID: 22047580 No abstract available.
Chronic kidney disease.
Levey AS, Coresh J. Levey AS, et al. Lancet. 2012 Jan 14;379(9811):165-80. doi: 10.1016/S0140-6736(11)60178-5. Epub 2011 Aug 15. Lancet. 2012. PMID: 21840587 Review.
Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate.
Grams ME, Sang Y, Levey AS, Matsushita K, Ballew S, Chang AR, Chow EK, Kasiske BL, Kovesdy CP, Nadkarni GN, Shalev V, Segev DL, Coresh J, Lentine KL, Garg AX; Chronic Kidney Disease Prognosis Consortium. Grams ME, et al. Among authors: levey as. N Engl J Med. 2016 Feb 4;374(5):411-21. doi: 10.1056/NEJMoa1510491. Epub 2015 Nov 6. N Engl J Med. 2016. PMID: 26544982 Free PMC article.
555 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page